Glenmark Pharmaceuticals informs about media release

04 Jun 2021 Evaluate

Glenmark Pharmaceuticals has informed that it has attached a media release on 4th June 2021 titled ‘Glenmark Pharmaceuticals receives ANDA approval for Theophylline Extended-Release Tablets, 300 mg and 450 mg: Granted competitive generic therapy (CGT) designation and is eligible for 180 days of CGT exclusivity on the 450 mg’ which is self?explanatory.

The above information is a part of company’s filings submitted to BSE.

Glenmark Pharma Share Price

1999.00 -2.05 (-0.10%)
28-Jan-2026 15:40 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1609.85
Dr. Reddys Lab 1224.30
Cipla 1331.80
Zydus Lifesciences 896.60
Lupin 2132.65
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×